Nishith Nb Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nishith Nb Patel has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Gavin James Murphy
Department of Cardiovascular Sciences and NIHR Cardiovascular Biomedical Research Centre, University of Leicester, Glenfield Hospital, Leicester, LE3 9QP, UK
16 shared publications - Gianni Davide Angelini
University of Bristol
10 shared publications Ceri Jones
Clinical Perfusion Scientist
4 shared publications- Gavin Iain Welsh
Bristol Renal, University of Bristol and Bristol Royal Hospital for Children, Bristol, UK
4 shared publications Hua Lin
Research Associate
4 shared publicationsParamita Ray
Consultant Anesthetist, Department of Anesthesia and Critical Care, Weston General Hospital, Weston-Super-Mare, United Kingdom
4 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Elsevier in Heart, Lung and Circulation
Coagulation Defects Promote False Lumen Patency in Type A Aortic Dissection
- 11 September 2026
- Published by Elsevier in Heart, Lung and Circulation
Open AccessCoagulation Defects Promote False Lumen Patency in Type A Aortic Dissection
- Open Access
- 12 October 2023
- Published by Wiley in American Journal of Hematology
- Vol. 98 (12) , 1953-1958
Severe autoimmune heparin‐induced thrombocytopenia postcardiac surgery: Implications for subsequent cardiac surgery
- 12 October 2023
- Published by Wiley in American Journal of Hematology
- Vol. 98 (12) , 1953-1958
Open AccessSevere autoimmune heparin‐induced thrombocytopenia postcardiac surgery: Implications for subsequent cardiac surgery
- Open Access
- 1 April 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (13) , 1089-1090
Restrictive transfusion practice in cardiac surgery patients is safe, but what transfusion threshold is safe for my patient?
This editorial refers to ‘Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis’†, by N. Shehata et al., on page 1081.
- 1 April 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (13) , 1089-1090
Open AccessRestrictive transfusion practice in cardiac surgery patients is safe, but what transfusion threshold is safe for my patient?
This editorial refers to ‘Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis’†, by N. Shehata et al., on page 1081.
- Open Access
- 25 January 2019
- Published by BMJ in Open Heart
- Vol. 6 (1) , e000864
Pharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: a systematic review and meta-analysis of randomised controlled trials
Objective: Quantify the efficacy of strategies to prevent contrast-induced acute kidney injury (CI-AKI) in high-risk patients undergoing coronary angiography (CAG) with or without percutaneous coronary intervention (PCI). Background: CI-AKI remains a common problem. The renoprotective efficacy of existing pharmacological agents remains uncertain in high-risk populations. Methods: Systematic review and meta-analysis of randomised controlled trials (RCTs) to compare different strategies versus hydration in patients with chronic kidney disease (CKD) undergoing CAG±PCI. Primary outcome was incident CI-AKI. Fixed-effects meta-analyses estimated ORs, 95% CIs and heterogeneity. Results: Forty-eight RCTs were included. Seven pharmacological strategies were evaluated by multiple RCTs and 10 by one RCT each. These had varying risk of bias; >25% of trials were at high risk of performance bias. Five strategies significantly reduced the odds of CI-AKI: N-acetylcysteine (NAC) (27 trials, 5694 participants; OR=0.77, 95% CI 0.65 to 0.91, p=0.002, I2=36%), ascorbic acid (four trials, 759 participants; OR=0.59, 95% CI 0.39 to 0.89, p=0.01, I2=0%), statin (two trials, 3234 participants; OR=0.59, 95% CI 0.39 to 0.89, p=0.75, I2=0%), trimetazidine (two trials, 214 participants; OR=0.27, 95% CI 0.10 to 0.71, p=0.01, I2=0%) and nicorandil (two trials, 389 participants; OR=0.47, 95% CI 0.23 to 0.94, p=0.03, I2=52%). Theophylline had a similar, but non-significant, effect. A subgroup analysis found that the benefit of NAC was highest in patients requiring a high-contrast dose. Conclusions: Several drugs are renoprotective in patients with CKD undergoing CAG±PCI. The evidence is strongest for NAC. We recommend that NAC should be used when a high dose of contrast is anticipated. Trial registration number: PROSPERO registration CRD42014014704. Open Science Framework link: https://osf.io/vxg7d/?view_only=62bad0404b18405abd39ff2ead2575a8
- 25 January 2019
- Published by BMJ in Open Heart
- Vol. 6 (1) , e000864
Open AccessPharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: a systematic review and meta-analysis of randomised controlled trials
Objective: Quantify the efficacy of strategies to prevent contrast-induced acute kidney injury (CI-AKI) in high-risk patients undergoing coronary angiography (CAG) with or without percutaneous coronary intervention (PCI). Background: CI-AKI remains a common problem. The renoprotective efficacy of existing pharmacological agents remains uncertain in high-risk populations. Methods: Systematic review and meta-analysis of randomised controlled trials (RCTs) to compare different strategies versus hydration in patients with chronic kidney disease (CKD) undergoing CAG±PCI. Primary outcome was incident CI-AKI. Fixed-effects meta-analyses estimated ORs, 95% CIs and heterogeneity. Results: Forty-eight RCTs were included. Seven pharmacological strategies were evaluated by multiple RCTs and 10 by one RCT each. These had varying risk of bias; >25% of trials were at high risk of performance bias. Five strategies significantly reduced the odds of CI-AKI: N-acetylcysteine (NAC) (27 trials, 5694 participants; OR=0.77, 95% CI 0.65 to 0.91, p=0.002, I2=36%), ascorbic acid (four trials, 759 participants; OR=0.59, 95% CI 0.39 to 0.89, p=0.01, I2=0%), statin (two trials, 3234 participants; OR=0.59, 95% CI 0.39 to 0.89, p=0.75, I2=0%), trimetazidine (two trials, 214 participants; OR=0.27, 95% CI 0.10 to 0.71, p=0.01, I2=0%) and nicorandil (two trials, 389 participants; OR=0.47, 95% CI 0.23 to 0.94, p=0.03, I2=52%). Theophylline had a similar, but non-significant, effect. A subgroup analysis found that the benefit of NAC was highest in patients requiring a high-contrast dose. Conclusions: Several drugs are renoprotective in patients with CKD undergoing CAG±PCI. The evidence is strongest for NAC. We recommend that NAC should be used when a high dose of contrast is anticipated. Trial registration number: PROSPERO registration CRD42014014704. Open Science Framework link: https://osf.io/vxg7d/?view_only=62bad0404b18405abd39ff2ead2575a8
- Open Access
- 21 May 2018
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 65 (8) , 868-872
Transfusion triggers in cardiac surgery: Where do we go from here?
- 21 May 2018
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 65 (8) , 868-872
Open AccessTransfusion triggers in cardiac surgery: Where do we go from here?
- Open Access
- 1 May 2018
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 314 (5) , F726-F735
Vascular endothelial cell changes in postcardiac surgery acute kidney injury
Acute kidney injury (AKI) is common complication of cardiac surgery; however, the phenotype of this condition is poorly defined. The aim of this study was to characterize changes in endothelial structure and function that underlie postcardiopulmonary bypass (post-CPB) AKI. Adult pigs ( n = 16) were randomized to undergo the following procedures ( n = 8 per group): group 1: sham operation, neck dissection with 2.5 h of general anesthesia; and group 2: CPB, 2.5 h of cardiopulmonary bypass. CPB resulted in the depletion of specific epitopes of glycosaminoglycans side chains of the endothelial glycocalyx: Dolichos biflorus agglutinin: mean difference (MD) [95% confidence interval (CI)], P value: −0.26 (−0.42, −0.09), P = 0.0024, Triticum vulgaris (wheat germ) agglutinin: −0.83 (−1.2, −0.38), P = 0.0005, and Ulex europaeus agglutinin 1: −0.25 (−0.49, −0.009), P = 0.041; endothelial membrane protein: thrombomodulin: −3.13 (−5.6, −0.65), P = 0.02; and adherens junction: VE-cadherin: −1.06 (−1.98, −0.145), P = 0.02. CPB also resulted in reductions in microvascular cortical perfusion: −0.62 (−1.02, −0.22), P = 0.006, and increased renal cortex adenosine levels: 2.32 (0.83, 3.8), P = 0.0059. These changes were accompanied by significant reduction in creatinine clearance at 1.5 h postintervention, MD 95% CI; −51.7 (−99.7, −3.7), P = 0.037, and at 24 h, MD (95% CI): −47.3 (−87.7, −7.6), P = 0.023, and proteinuria immediately postintervention MD (95% CI): 18.79 (2.17, 35.4), P = 0.03 vs. sham. In our experimental CPB model, endothelial injury was associated with loss of autoregulation, increase in microvascular permeability, and reduced glomerular filtration. Interventions that promote endothelial homeostasis may have clinical utility in the prevention of postcardiac surgery AKI.
- 1 May 2018
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 314 (5) , F726-F735
Open AccessVascular endothelial cell changes in postcardiac surgery acute kidney injury
Acute kidney injury (AKI) is common complication of cardiac surgery; however, the phenotype of this condition is poorly defined. The aim of this study was to characterize changes in endothelial structure and function that underlie postcardiopulmonary bypass (post-CPB) AKI. Adult pigs ( n = 16) were randomized to undergo the following procedures ( n = 8 per group): group 1: sham operation, neck dissection with 2.5 h of general anesthesia; and group 2: CPB, 2.5 h of cardiopulmonary bypass. CPB resulted in the depletion of specific epitopes of glycosaminoglycans side chains of the endothelial glycocalyx: Dolichos biflorus agglutinin: mean difference (MD) [95% confidence interval (CI)], P value: −0.26 (−0.42, −0.09), P = 0.0024, Triticum vulgaris (wheat germ) agglutinin: −0.83 (−1.2, −0.38), P = 0.0005, and Ulex europaeus agglutinin 1: −0.25 (−0.49, −0.009), P = 0.041; endothelial membrane protein: thrombomodulin: −3.13 (−5.6, −0.65), P = 0.02; and adherens junction: VE-cadherin: −1.06 (−1.98, −0.145), P = 0.02. CPB also resulted in reductions in microvascular cortical perfusion: −0.62 (−1.02, −0.22), P = 0.006, and increased renal cortex adenosine levels: 2.32 (0.83, 3.8), P = 0.0059. These changes were accompanied by significant reduction in creatinine clearance at 1.5 h postintervention, MD 95% CI; −51.7 (−99.7, −3.7), P = 0.037, and at 24 h, MD (95% CI): −47.3 (−87.7, −7.6), P = 0.023, and proteinuria immediately postintervention MD (95% CI): 18.79 (2.17, 35.4), P = 0.03 vs. sham. In our experimental CPB model, endothelial injury was associated with loss of autoregulation, increase in microvascular permeability, and reduced glomerular filtration. Interventions that promote endothelial homeostasis may have clinical utility in the prevention of postcardiac surgery AKI.
- 1 February 2018
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 128 (2) , 375-385
A Comparison of Red Cell Rejuvenation versus Mechanical Washing for the Prevention of Transfusion-associated Organ Injury in Swine
Background: We evaluated the effects of two interventions that modify the red cell storage lesion on kidney and lung injury in experimental models of transfusion. Methods: White–landrace pigs (n = 32) were allocated to receive sham transfusion (crystalloid), 14-day stored allogeneic red cells, 14-day red cells washed using the red cells washing/salvage system (CATS; Fresenius, Germany), or 14-day red cells rejuvenated using the inosine solution (Rejuvesol solution; Zimmer Biomet, USA) and washed using the CATS device. Functional, biochemical, and histologic markers of organ injury were assessed for up to 24 h posttransfusion. Results: Transfusion of 14 day red cells resulted in lung injury (lung injury score vs. sham, mean difference −0.3 (95% CI, −0.6 to −0.1; P = 0.02), pulmonary endothelial dysfunction, and tissue leukocyte sequestration. Mechanical washing reduced red cell–derived microvesicles but increased cell-free hemoglobin in 14-day red cell units. Transfusion of washed red cells reduced leukocyte sequestration but did not reduce the lung injury score (mean difference −0.2; 95% CI, −0.5 to 0.1; P = 0.19) relative to 14-day cells. Transfusion of washed red cells also increased endothelial activation and kidney injury. Rejuvenation restored adenosine triphosphate to that of fresh red cells and reduced microvesicle concentrations without increasing cell-free hemoglobin release. Transfusion of rejuvenated red cells reduced plasma cell-free hemoglobin, leukocyte sequestration, and endothelial dysfunction in recipients and reduced lung and kidney injury relative to 14-day or washed 14-day cells. Conclusions: Reversal of the red cell storage lesion by rejuvenation reduces transfusion-associated organ injury in swine.
- 1 February 2018
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 128 (2) , 375-385
A Comparison of Red Cell Rejuvenation versus Mechanical Washing for the Prevention of Transfusion-associated Organ Injury in Swine
Background: We evaluated the effects of two interventions that modify the red cell storage lesion on kidney and lung injury in experimental models of transfusion. Methods: White–landrace pigs (n = 32) were allocated to receive sham transfusion (crystalloid), 14-day stored allogeneic red cells, 14-day red cells washed using the red cells washing/salvage system (CATS; Fresenius, Germany), or 14-day red cells rejuvenated using the inosine solution (Rejuvesol solution; Zimmer Biomet, USA) and washed using the CATS device. Functional, biochemical, and histologic markers of organ injury were assessed for up to 24 h posttransfusion. Results: Transfusion of 14 day red cells resulted in lung injury (lung injury score vs. sham, mean difference −0.3 (95% CI, −0.6 to −0.1; P = 0.02), pulmonary endothelial dysfunction, and tissue leukocyte sequestration. Mechanical washing reduced red cell–derived microvesicles but increased cell-free hemoglobin in 14-day red cell units. Transfusion of washed red cells reduced leukocyte sequestration but did not reduce the lung injury score (mean difference −0.2; 95% CI, −0.5 to 0.1; P = 0.19) relative to 14-day cells. Transfusion of washed red cells also increased endothelial activation and kidney injury. Rejuvenation restored adenosine triphosphate to that of fresh red cells and reduced microvesicle concentrations without increasing cell-free hemoglobin release. Transfusion of rejuvenated red cells reduced plasma cell-free hemoglobin, leukocyte sequestration, and endothelial dysfunction in recipients and reduced lung and kidney injury relative to 14-day or washed 14-day cells. Conclusions: Reversal of the red cell storage lesion by rejuvenation reduces transfusion-associated organ injury in swine.
- Open Access
- 1 November 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 246, 32-36
Long-term survival after off-pump versus on-pump coronary artery bypass graft surgery. Does completeness of revascularization play a role?
- 1 November 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 246, 32-36
Open AccessLong-term survival after off-pump versus on-pump coronary artery bypass graft surgery. Does completeness of revascularization play a role?
- 1 October 2017
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 31 (4) , 230-235
Evidence-Based Red Blood Cell Transfusion Practices in Cardiac Surgery
- 1 October 2017
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 31 (4) , 230-235
Evidence-Based Red Blood Cell Transfusion Practices in Cardiac Surgery
- Open Access
- 25 March 2016
- Published by BMJ in Open Heart
- Vol. 3 (1) , e000338
Long-term survival after surgical aortic valve replacement among patients over 65 years of age
Objective Surgical aortic valve replacement (AVR) remains the gold standard therapy for severe aortic stenosis. Long-term survival data following AVR is required. Our objective was to provide a detailed contemporary benchmark of long-term survival following AVR among elderly patients (≥65 years) in the UK. Methods We conducted a retrospective cohort study of 1815 adult patients undergoing surgical AVR± coronary artery bypass graft (CABG) surgery at a single UK centre between 1996 and 2011. Our main outcome was patient survival, which was assessed by linkage to census records at the Office for National Statistics. Results The mean age of the cohort was 75 (±5.6) years. Patients in the AVR alone group had a slightly higher median survival of 10.9 (95% CI 10.5 to 11.8) years than the AVR+CABG group which had a median survival of 9.6 (95% CI 8.7 to 10.1) years (p=0.001 of log-rank test (LRT) for equality of survivor functions). The presence of chronic kidney disease, severely impaired left ventricular function or being a current smoker were each associated with a ≥50% increased risk of long-term mortality. Comparison of our study cohort patients and the reference (operation year, age and gender matched) UK population suggested no difference in survival probability up to 8 years (p=0.55). However, for longer periods of follow-up, the difference became increasingly significant (pConclusions Long-term survival following surgical AVR in patients over 65 years of age is excellent and up to 8 years is comparable to the matched general population.
- 25 March 2016
- Published by BMJ in Open Heart
- Vol. 3 (1) , e000338
Open AccessLong-term survival after surgical aortic valve replacement among patients over 65 years of age
Objective Surgical aortic valve replacement (AVR) remains the gold standard therapy for severe aortic stenosis. Long-term survival data following AVR is required. Our objective was to provide a detailed contemporary benchmark of long-term survival following AVR among elderly patients (≥65 years) in the UK. Methods We conducted a retrospective cohort study of 1815 adult patients undergoing surgical AVR± coronary artery bypass graft (CABG) surgery at a single UK centre between 1996 and 2011. Our main outcome was patient survival, which was assessed by linkage to census records at the Office for National Statistics. Results The mean age of the cohort was 75 (±5.6) years. Patients in the AVR alone group had a slightly higher median survival of 10.9 (95% CI 10.5 to 11.8) years than the AVR+CABG group which had a median survival of 9.6 (95% CI 8.7 to 10.1) years (p=0.001 of log-rank test (LRT) for equality of survivor functions). The presence of chronic kidney disease, severely impaired left ventricular function or being a current smoker were each associated with a ≥50% increased risk of long-term mortality. Comparison of our study cohort patients and the reference (operation year, age and gender matched) UK population suggested no difference in survival probability up to 8 years (p=0.55). However, for longer periods of follow-up, the difference became increasingly significant (pConclusions Long-term survival following surgical AVR in patients over 65 years of age is excellent and up to 8 years is comparable to the matched general population.